196 related articles for article (PubMed ID: 6202703)
1. Induction and origin of hepatocytes in rat pancreas.
Reddy JK; Rao MS; Qureshi SA; Reddy MK; Scarpelli DG; Lalwani ND
J Cell Biol; 1984 Jun; 98(6):2082-90. PubMed ID: 6202703
[TBL] [Abstract][Full Text] [Related]
2. Induction of hepatocytes in the pancreas of copper-depleted rats following copper repletion.
Rao MS; Subbarao V; Reddy JK
Cell Differ; 1986 Mar; 18(2):109-17. PubMed ID: 3513967
[TBL] [Abstract][Full Text] [Related]
3. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
Awasthi YC; Singh SV; Goel SK; Reddy JK
Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318
[TBL] [Abstract][Full Text] [Related]
4. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G
Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161
[TBL] [Abstract][Full Text] [Related]
5. Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects.
Rao MS; Thorgeirsson S; Reddy MK; Lalwani ND; Evarts RE; Usman MI; Singh B; Reddy JK
Am J Pathol; 1986 Sep; 124(3):519-27. PubMed ID: 3532814
[TBL] [Abstract][Full Text] [Related]
6. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes.
Foxworthy PS; White SL; Hoover DM; Eacho PI
Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728
[TBL] [Abstract][Full Text] [Related]
7. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.
Thangada S; Alvares K; Mangino M; Usman MI; Rao MS; Reddy JK
FEBS Lett; 1989 Jul; 250(2):205-10. PubMed ID: 2753129
[TBL] [Abstract][Full Text] [Related]
8. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
9. Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats.
Srinivasan SR; Chow CK; Glauert HP
Toxicology; 1990 Jun; 62(3):321-32. PubMed ID: 2389247
[TBL] [Abstract][Full Text] [Related]
10. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
Rao MS; Subbarao V
Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
[TBL] [Abstract][Full Text] [Related]
11. The effect of ciprofibrate on gastric secretion in the rat.
Eason CT; Pattison A; Howells DD; Bonner FW
J Pharm Pharmacol; 1988 Jul; 40(7):512-3. PubMed ID: 2904995
[TBL] [Abstract][Full Text] [Related]
12. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes.
Blaauboer BJ; van Holsteijn CW; Bleumink R; Mennes WC; van Pelt FN; Yap SH; van Pelt JF; van Iersel AA; Timmerman A; Schmid BP
Biochem Pharmacol; 1990 Aug; 40(3):521-8. PubMed ID: 2383284
[TBL] [Abstract][Full Text] [Related]
13. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
Rao MS; Lalwani ND; Watanabe TK; Reddy JK
Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
[TBL] [Abstract][Full Text] [Related]
15. Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators.
Reddy JK; Jirtle RL; Watanabe TK; Reddy NK; Michalopoulos G; Qureshi SA
Cancer Res; 1984 Jun; 44(6):2582-9. PubMed ID: 6372995
[TBL] [Abstract][Full Text] [Related]
16. Induction of pancreatic acinar cell proliferation by thyroid hormone.
Ledda-Columbano GM; Perra A; Pibiri M; Molotzu F; Columbano A
J Endocrinol; 2005 Jun; 185(3):393-9. PubMed ID: 15930165
[TBL] [Abstract][Full Text] [Related]
17. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
[TBL] [Abstract][Full Text] [Related]
18. [The pharmacokinetics of hypolipemic agents. 6. Is 2-(4-(2,2-dichlorocyclopropyl)-phenoxy)-propane a metabolite of the hypolipemic ciprofibrate?].
Oelschläger H; Rothley D; Hellwich KH; Schmidt W
Arch Pharm (Weinheim); 1989 Oct; 322(10):629-32. PubMed ID: 2624522
[TBL] [Abstract][Full Text] [Related]
19. Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators.
Cherkaoui Malki M; Lone YC; Corral-Debrinski M; Latruffe N
Biochem Biophys Res Commun; 1990 Dec; 173(3):855-61. PubMed ID: 2268348
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Role of carnitine.
Gerondaes P; Alberti KG; Agius L
Biochem J; 1988 Jul; 253(1):161-7. PubMed ID: 3048253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
